½ÃÀ庸°í¼­
»óǰÄÚµå
1587529

Áú·®ºÐ¼® ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® ¸®Æ÷Æ® : Á¦Ç°º°, ¿ëµµº°, ±â¼úº°, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº°, ºÎ¹®º° ¿¹Ãø(2025-2030³â)

Mass Spectrometry Market Size, Share & Trends Analysis Report By Product (Instruments, Consumables & Services), By Application (Proteomics, Metabolomics), By Technology, By End-use, By Region, And Segment Forecasts, 2025 - 2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Grand View Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 120 Pages | ¹è¼Û¾È³» : 2-10ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

Áú·®ºÐ¼® ½ÃÀåÀÇ ¼ºÀå°ú µ¿Çâ

Grand View Research, Inc.ÀÇ ÃֽЏ®Æ÷Æ®¿¡ µû¸£¸é ¼¼°èÀÇ Áú·®ºÐ¼® ½ÃÀå ±Ô¸ð´Â 2025-2030³â CAGR 7.97%¸¦ ±â·ÏÇϸç, 2030³â¿¡´Â 106¾ï 5,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¸¸¼ºÁúȯ ¹× °¨¿°¼º ÁúȯÀÇ Á¶±â ¹ß°ß¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö°í Áø´Ü ±â±âÀÇ »õ·Î¿î ±â¼ú ¹ßÀüÀÌ ½ÃÀå ¼ºÀåÀ» Å©°Ô ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¶ÇÇÑ Áúº´ Áø´ÜÀ» À§ÇÑ ºñ¿ë È¿À²ÀûÀÎ ÀÚµ¿È­ ±â¼ú¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖÀ¸¸ç, ÀÌ´Â Áú·®ºÐ¼® ±â¼ú¿¡ ´ëÇÑ ¼ö¿ä¸¦ Áõ°¡½ÃÄÑ ¼ºÀå¿¡ ±àÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

COVID-19 ÆÒµ¥¹ÍÀ¸·Î ÀÎÇØ ÃÖ±Ù ¹ÙÀÌ·¯½ºÇÐ ¿¬±¸ ºÐ¾ß¿¡¼­´Â ¹é½Å °³¹ß¿¡ ´ëÇÑ ¼ö¿ä°¡ ±ÞÁõÇϰí ÀÖ½À´Ï´Ù. ¿©±â¼­ Áú·®ºÐ¼®Àº SARS-CoV-2ÀÇ ¹ÙÀÌ·¯½º ±¸Á¶ ¿¬±¸¿¡ Àû¿ëµÇ°í ÀÖ½À´Ï´Ù. ÀÌ ±â¼úÀº ¹ÙÀÌ·¯½º¿Í °ü·ÃµÈ º¹ÀâÇÑ ´Ü¹éÁú ±¸Á¶¿Í ´Ü¹éÁú °£ »óÈ£ ÀÛ¿ëÀ» ¿¬±¸ÇÏ´Â µ¥¿¡µµ »ç¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù. µû¶ó¼­ COVID-19 ¹é½Å ¹× ÀǾàǰ °³¹ß¿¡ Âü¿©ÇÏ´Â ´Ù¾çÇÑ Á¦¾à ¹× »ý¸í°øÇÐ ±â¾÷ÀÌ Àåºñ ¹× ¼Ò¸ðǰ¿¡ ´ëÇÑ ¼ö¿ä¸¦ Áõ°¡½Ãų °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¶ÇÇÑ ´Ù¾çÇÑ Çмú±â°ü°ú ±â¾÷Àº ´Ü¹éÁúüÇÐ ½ÃÀåÀÇ Áú·®ºÐ¼® ¼ö¿ä¸¦ Áö¿øÇϱâ À§ÇÑ Á¦Ç° °³¹ß Àü·«À» ¼ö¸³Çϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î 2022³â 9¿ù, ³ë½º¿þ½ºÅÏ´ëÇб³ ´Ü¹éÁúüÇÐ ¿ì¼ö¼º ¼¾ÅÍ(Northwestern University Proteomics Center of Excellence)ÀÇ µð·ºÅÍ´Â ¼Õ»óµÇÁö ¾ÊÀº ÇÁ·ÎÅ׿ÀÆûÀÇ ½Äº°À» °­È­ÇÏ´Â »õ·Î¿î À̹Ì¡ Á¢±Ù¹ý °³¹ß¿¡ °üÇÑ ³í¹®À» ¹ßÇ¥Çß½À´Ï´Ù. ¿¬±¸ÆÀÀº Proteoform Imaging Mass Spectrometry(PiMS) ½Ã½ºÅÛÀ» ±¸ÃàÇÏ¿© »õ·Î¿î ¹ÙÀÌ¿À¸¶Ä¿ °ËÃâ, ºÐÀÚ Á¶Á÷ ¸ÅÇÎ, Áúº´ Áø´Ü °³¼± µî ´Ù¾çÇÑ ¿ëµµ¿¡¼­ Áú·®ºÐ¼®À» Áö¿øÇÒ °ÍÀ¸·Î ±â´ëµÇ°í ÀÖ½À´Ï´Ù.

¶ÇÇÑ Thermo Fisher ScientificÀº 2022³â 10¿ù¿¡ ´Ü¹éÁúüÇÐ ¹× ¹ÙÀÌ¿ÀÁ¦¾à ÃÖÁ¾»ç¿ëÀÚ°¡ ȹ±âÀûÀÎ ¹ßÀüÀ» ÀÌ·ê ¼ö ÀÖ´Â Áú·®ºÐ¼® ¼Ò¸ðǰ ¹× ÀåºñÀÇ Ãâ½Ã¸¦ ¹ßÇ¥Çß½À´Ï´Ù. Thermo Scientific Orbitrap Ascend Tribrid Áú·®ºÐ¼®±â·Î ¾Ë·ÁÁø ÀÌ Àåºñ´Â ¿©·¯ ÀÌ¿ÂÀ» Á÷Á¢ °ËÃâÇÏ´Â »õ·Î¿î ±â´ÉÀ» Á¦°øÇÏ¿© ºü¸¥ °ËÃâ°ú ÇÔ²² ½Ã·á¿¡ ´ëÇÑ ´õ ±íÀº ÀλçÀÌÆ®À» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

Áú·®ºÐ¼® ½ÃÀå º¸°í¼­ ÇÏÀ̶óÀÌÆ®

  • Àåºñ ºÎ¹®ÀÌ °¡Àå Å« ¸ÅÃâ Á¡À¯À²À» Â÷ÁöÇÏ¸ç ¿¹Ãø ±â°£ Áß CAGR 7.28%·Î Å©°Ô ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
  • 4±ØÇü ¾×ü Å©·Î¸¶Åä±×·¡ÇÁ Áú·®ºÐ¼®±â°¡ 2024³â 37.3%ÀÇ ÃÖ´ë Á¡À¯À²·Î ½ÃÀåÀ» Àå¾ÇÇß½À´Ï´Ù.
  • ´Ü¹éÁúüÇÐ ºÎ¹®Àº 2024³â 46.21%·Î °¡Àå Å« Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù. Áú·®ºÐ¼® ±â¹Ý ´Ü¹éÁúüÇÐ ¿¬±¸´Â ´Ü¹éÁúÀÇ Á¤·®Àû ÇÁ·ÎÆÄÀϸµ°ú ´Ü¹éÁú °£ »óÈ£ ÀÛ¿ëÀ» ¿¬±¸Çϱâ À§ÇÑ Á¾ÇÕÀûÀÎ ±â¼úÀÔ´Ï´Ù.
  • Á¦¾à ¹× »ý¸í°øÇÐ ±â¾÷ ºÎ¹®ÀÌ 2024³â ½ÃÀåÀ» Àå¾ÇÇÒ °ÍÀ¸·Î Àü¸ÁµÇ´Â ÀÌÀ¯´Â Á¦¾à »ê¾÷¿¡¼­ ½Å¾à °³¹ß ¹× ½ÃÀå °³¹ß ÇÁ·Î¼¼½º¸¦ À§ÇØ Áú·®ºÐ¼®À» ÀÌ¿ëÇÑ ´Ü¹éÁú ½ÃÄö½ÌÀÌ ³Î¸® äÅõǰí Àֱ⠶§¹®ÀÔ´Ï´Ù.
  • ºÏ¹Ì Áú·®ºÐ¼® ½ÃÀåÀº 2024³â 41.63%ÀÇ ¸ÅÃâ Á¡À¯À²·Î Àü ¼¼°è ½ÃÀå Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù. ÀÌ Å« Á¡À¯À²Àº ÁÖ¿ä ½ÃÀå ÁøÃâ±â¾÷, ±âÁ¸ Çмú±â°ü, Á¦¾à ȸ»ç ¹× ¿¬±¸¼¾ÅÍÀÇ Á¸Àç¿Í »ý¸í °øÇÐ ¹× ½Å¾à °³¹ß ¹× ¿¬±¸°³¹ßÀ» À§ÇÑ È°¹ßÇÑ ÀÚ±Ý Á¶´Þ ±âȸ·Î ÀÎÇØ ¹ß»ýÇß½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§

Á¦2Àå °³¿ä

Á¦3Àå Áú·®ºÐ¼® ½ÃÀå º¯¼ö, µ¿Çâ, ¹üÀ§

  • ½ÃÀå °èÅë Àü¸Á
    • ¸ð½ÃÀå Àü¸Á
    • °ü·Ã/º¸Á¶ ½ÃÀå Àü¸Á
  • ½ÃÀå ¿ªÇÐ
    • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ ºÐ¼®
    • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ ºÐ¼®
    • ½ÃÀå ±âȸ
    • ½ÃÀåÀÌ ÇØ°áÇØ¾ß ÇÒ °úÁ¦
  • ºñÁî´Ï½º ȯ°æ ºÐ¼®
    • SWOT ºÐ¼®, ¿äÀκ°(Á¤Ä¡¡¤¹ý·ü, °æÁ¦, »çȸ, ȯ°æ, ±â¼ú)
    • Porter's Five Forces ºÐ¼®
  • Áú·®ºÐ¼® ½ÃÀå¿¡ ´ëÇÑ COVID-19ÀÇ ¿µÇâ

Á¦4Àå Áú·®ºÐ¼® ½ÃÀå - ºÎ¹® ºÐ¼®, Á¦Ç°º°, 2018-2030³â(100¸¸ ´Þ·¯)

  • Áú·®ºÐ¼® ½ÃÀå : Á¦Ç° º¯µ¿ ºÐ¼®
  • Á¦Ç°º°
    • ±â±â
    • ¼Ò¸ðǰ°ú ¼­ºñ½º

Á¦5Àå Áú·®ºÐ¼® ½ÃÀå - ºÎ¹® ºÐ¼®, ±â¼úº°, 2018-2030³â(100¸¸ ´Þ·¯)

  • Áú·®ºÐ¼® ½ÃÀå : ±â¼ú º¯µ¿ ºÐ¼®
  • ±â¼úº°
    • Äõµå·¯ÇÃÇü ¾×ü Å©·Î¸¶Åä±×·¡ÇÇ Áú·®ºÐ¼®¹ý
    • °¡½º Å©·Î¸¶Åä±×·¡ÇÇ Áú·®ºÐ¼®¹ý(Gc-Ms)
    • Ǫ¸®¿¡ º¯È¯ Áú·®ºÐ¼®¹ý(Ft-Ms)
    • ºñÇà ½Ã°£Çü Áú·®ºÐ¼®¹ý(Tofms)
    • ¸ÅÆ®¸¯½º Áö¿ø ·¹ÀÌÀú ÀÌÅ»/ÀÌ¿ÂÈ­ ºñÇà ½Ã°£Çü Áú·®ºÐ¼®¹ý(Maldi-Tof)
    • Àڱ⠺ι® Áú·®ºÐ¼®¹ý
    • ±âŸ

Á¦6Àå Áú·®ºÐ¼® ½ÃÀå - ºÎ¹® ºÐ¼®, ¿ëµµº°, 2018-2030³â(100¸¸ ´Þ·¯)

  • Áú·®ºÐ¼® ½ÃÀå : ¿ëµµ º¯µ¿ ºÐ¼®
  • ¿ëµµº°
    • ´Ü¹éÁúüÇÐ
    • ´ë»çüÇÐ
    • ±Û¸®Äڹͽº
    • ±âŸ

Á¦7Àå Áú·®ºÐ¼® ½ÃÀå - ºÎ¹® ºÐ¼®, ÃÖÁ¾ ¿ëµµº°, 2018-2030³â(100¸¸ ´Þ·¯)

  • Áú·®ºÐ¼® ½ÃÀå : ÃÖÁ¾ ¿ëµµ º¯µ¿ ºÐ¼®
  • ÃÖÁ¾ ¿ëµµº°
    • Á¤ºÎ±â°ü°ú Çмú±â°ü
    • Á¦¾à¡¤¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö ±â¾÷
    • ±âŸ

Á¦8Àå Áú·®ºÐ¼® ½ÃÀå - ºÎ¹® ºÐ¼®, Áö¿ªº°, 2018-2030³â(100¸¸ ´Þ·¯)

  • Áú·®ºÐ¼® ½ÃÀå : Áö¿ªº° Àü¸Á
  • ºÏ¹Ì
    • ºÏ¹ÌÀÇ Áú·®ºÐ¼® ½ÃÀå ÃßÁ¤¡¤¿¹Ãø, 2018-2030³â
    • ¹Ì±¹
    • ij³ª´Ù
  • À¯·´
    • À¯·´ÀÇ Áú·®ºÐ¼® ½ÃÀå ÃßÁ¤°ú ¿¹Ãø, 2018-2030³â
    • ¿µ±¹
    • µ¶ÀÏ
    • ÇÁ¶û½º
    • ½ºÆäÀÎ
    • ÀÌÅ»¸®¾Æ
    • µ§¸¶Å©
    • ½º¿þµ§
    • ³ë¸£¿þÀÌ
    • ±âŸ À¯·´ÀÇ Áú·®ºÐ¼® ½ÃÀå ÃßÁ¤¡¤¿¹Ãø, 2018-2030³â
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ Áú·®ºÐ¼® ½ÃÀå ÃßÁ¤°ú ¿¹Ãø, 2018-2030³â
    • ÀϺ»
    • Áß±¹
    • Àεµ
    • È£ÁÖ
    • ű¹
    • Çѱ¹
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ Áú·®ºÐ¼® ½ÃÀå ÃßÁ¤¡¤¿¹Ãø, 2018-2030³â
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ¶óƾ¾Æ¸Þ¸®Ä«ÀÇ Áú·®ºÐ¼® ½ÃÀå ÃßÁ¤°ú ¿¹Ãø, 2018-2030³â
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
    • ¾Æ¸£ÇîÆ¼³ª
    • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«ÀÇ Áú·®ºÐ¼® ½ÃÀå ÃßÁ¤¡¤¿¹Ãø, 2018-2030³â
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ Áú·®ºÐ¼® ½ÃÀå ÃßÁ¤°ú ¿¹Ãø, 2018-2030³â
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®
    • Äí¿þÀÌÆ®

Á¦9Àå °æÀï ±¸µµ

  • ±â¾÷ ºÐ·ù
  • ÁÖ¿ä ½ÃÀå Âü¿© ±â¾÷¿¡ ÀÇÇÑ ÃÖ±Ù µ¿Çâ°ú ¿µÇ⠺м®
  • ±â¾÷ ½ÃÀå Á¡À¯À² ºÐ¼®, 2024³â
  • ÁÖ¿ä ±â¾÷ °³¿ä
    • THERMO FISHER SCIENTIFIC, INC.
    • AGILENT TECHNOLOGIES, INC.
    • DANAHER CORPORATION(SCEIX)
    • WATERS CORPORATION
    • BRUKER CORPORATION
    • SHIMADZU CORPORATION
    • PERKINELMER, INC.
    • RIGAKU CORPORATION
    • LECO CORPORATION
    • JEOL LTD.

Á¦10Àå °á·Ð

KSA 24.11.25

Mass Spectrometry Market Growth & Trends:

The global mass spectrometry market size is expected to reach USD 10.65 billion by 2030, registering a CAGR of 7.97% from 2025 to 2030, according to a new report by Grand View Research, Inc. Rising awareness regarding early detection of chronic and infectious diseases and emerging technological advancements in diagnostic instruments are expected to significantly drive the market growth. In addition, there has been an increase in demand for cost-effective and automated techniques for disease diagnosis which is anticipated to increase the demand for mass spectrometry techniques and positively affect the growth.

The COVID-19 pandemic has boosted the demand for vaccine development due to recent advancements in virology-based research. Here, mass spectrometry has applications for the study of viral structure for SARS-CoV-2. The technique can also be used to study complex protein structures and protein-protein interactions associated with the virus. Hence, various pharmaceutical and biotechnology companies involved in COVID-19 vaccine and drug development efforts are anticipated to increase the demand for instruments and consumables.

In addition, various academic institutions and companies are indulging in product development strategies to support the demand for mass spectrometry from the proteomic market. For instance, in September 2022, the director of Northwestern's Proteomics Center of Excellence published a paper on the development of a new imaging approach to enhance the identification of intact proteoforms. The team of researchers has built a Proteoform Imaging Mass Spectrometry (PiMS) system which is anticipated to assist mass spectrometry in various applications, including the detection of novel biomarkers, mapping of molecular tissue, and improvement in disease diagnosis.

Similarly, in October 2022, Thermo Fisher Scientific, Inc. announced the launch of mass spectrometry consumables and instrument that allows end-users in proteomics and biopharma to achieve significant breakthroughs. The instrument, known as Thermo Scientific Orbitrap Ascend Tribrid mass spectrometer, provides a new capability to direct multiple ions and enables to gain deeper insights into samples, along with rapid detection.

Mass Spectrometry Market Report Highlights:

  • The instruments segment dominated the market with the largest revenue share and is expected to grow at a significant CAGR of 7.28% over the forecast period due to the presence of a large number of companies offering different types of mass spectrometry instruments.
  • Quadrupole Liquid Chromatography-Mass Spectrometry dominated the market with the largest share of 37.3% in 2024.
  • The proteomics segment held the largest market share of 46.21% in 2024. Mass spectrometry-based proteomics research is a comprehensive technique for quantitative profiling of proteins and studying protein-protein interactions.
  • The pharmaceutical and biotechnology companies segment dominated the market in 2024 due to the extensive adoption of protein sequencing using mass spectrometry in the pharmaceutical industry for drug discovery and development processes.
  • The North America mass spectrometry market dominated globally in 2024 with a revenue share of 41.63%. This large share is due to the presence of key market players, established academic institutions, pharmaceutical companies, and research centers, coupled with robust funding opportunities for R&D in biotechnology and drug discovery & development.

Table of Contents

Chapter 1 Methodology And Scope

  • 1.1 Market Segmentation And Scope
  • 1.2 Regional Scope
    • 1.2.1 Segment Definitions
      • 1.2.1.1 Product Segment
      • 1.2.1.2 Technology Segment
      • 1.2.1.3 Application Segment
      • 1.2.1.4 End Use Segment
  • 1.3 Estimates And Forecast Timeline
  • 1.4 Objectives
    • 1.4.1 Objective - 1
    • 1.4.2 Objective - 2
    • 1.4.3 Objective - 3
  • 1.5 Research Methodology
  • 1.6 Information Procurement
    • 1.6.1 Purchased Database
    • 1.6.2 Gvr's Internal Database
    • 1.6.3 Secondary Sources
    • 1.6.4 Primary Research
  • 1.7 Information Or Data Analysis
  • 1.8 Market Formulation & Validation
  • 1.9 Model Details
    • 1.9.1 Commodity Flow Analysis
  • 1.10 Research Assumptions
  • 1.11 List Of Secondary Sources

Chapter 2 Executive Summary

  • 2.1 Market Snapshot
  • 2.2 Product And Technology Segment Snapshot
  • 2.3 Application And End Use Segment Snapshot
  • 2.4 Competitive Landscape Snapshot

Chapter 3 Mass Spectrometry Market Variables, Trends, And Scope

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent Market Outlook
    • 3.1.2 Related/Ancillary Market Outlook
  • 3.2 Market Dynamics
    • 3.2.1 Market Driver Analysis
      • 3.2.1.1 Increasing R&D In Pharmaceutical And Biotechnology Industries Is Driving The Adoption Of Mass Spectrometers
      • 3.2.1.2 Advancements In Proteomics Research Are Broadening The Applications Of Mass Spectrometry
      • 3.2.1.3 Acceleration In Biomedical Research
    • 3.2.2 Market Restraint Analysis
      • 3.2.2.1 Stringent Regulatory Framework Can Limit The Market Growth
      • 3.2.2.2 Lack Of Skilled Operators And Qualified Professionals May Hinder The Market Growth.
    • 3.2.3 Market Opportunity
      • 3.2.3.1 Technological Advancements
    • 3.2.4 Market Challenges
      • 3.2.4.1 The Lack Of Comprehensive Validation Studies
  • 3.3 Business Environment Analysis
    • 3.3.1 Swot Analysis; By Factor (Political & Legal, Economic, Social, Environmental, And Technological)
    • 3.3.2 Porter's Five Forces Analysis
  • 3.4 Covid-19 Impact On The Mass Spectrometry Market

Chapter 4 Mass Spectrometry Market - Segment Analysis, By Product, 2018 - 2030 (USD Million)

  • 4.1 Mass Spectrometry Market: Product Movement Analysis
  • 4.2 Mass Spectrometry Market Estimates & Forecast, By Product (USD Million)
    • 4.2.1 Instruments
    • 4.2.2 Consumables & Services

Chapter 5 Mass Spectrometry Market - Segment Analysis, By Technology, 2018 - 2030 (USD Million)

  • 5.1 Mass Spectrometry Market: Technology Movement Analysis
  • 5.2 Mass Spectrometry Market Estimates & Forecast, By Technology (USD Million)
    • 5.2.1 Quadrupole Liquid Chromatography-Mass Spectrometry
    • 5.2.2 Gas Chromatography-Mass Spectrometry (Gc-Ms)
    • 5.2.3 Fourier Transform-Mass Spectrometry (Ft-Ms)
    • 5.2.4 Time-Of-Flight Mass Spectrometry (Tofms)
    • 5.2.5 Matrix Assisted Laser Desorption/Ionization-Time-Of-Flight Mass Spectrometry (Maldi-Tof)
    • 5.2.6 Magnetic Sector Mass Spectrometry
    • 5.2.7 Others

Chapter 6 Mass Spectrometry Market - Segment Analysis, By Application, 2018 - 2030 (USD Million)

  • 6.1 Mass Spectrometry Market: Application Movement Analysis
  • 6.2 Mass Spectrometry Market Estimates & Forecast, By Application (USD Million)
    • 6.2.1 Proteomics
    • 6.2.2 Metabolomics
    • 6.2.3 Glycomics
    • 6.2.4 Others

Chapter 7 Mass Spectrometry Market - Segment Analysis, By End Use, 2018 - 2030 (USD Million)

  • 7.1 Mass Spectrometry Market: End-Use Movement Analysis
  • 7.2 Mass Spectrometry Market Estimates & Forecast, By End Use (USD Million)
    • 7.2.1 Government & Academic Institutions
    • 7.2.2 Pharmaceutical & Biotechnology Companies
    • 7.2.3 Others

Chapter 8 Mass Spectrometry Market - Segment Analysis, By Region, 2018 - 2030 (USD Million)

  • 8.1 Mass Spectrometry Market: Regional Outlook
  • 8.2 North America
    • 8.2.1 North America Mass Spectrometry Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.2.2 U.S.
      • 8.2.2.1 Key Country Dynamics
      • 8.2.2.2 U.S. Mass Spectrometry Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.2.2.3 Competitive Scenario
      • 8.2.2.4 Regulatory Framework
    • 8.2.3 Canada
      • 8.2.3.1 Key Country Dynamics
      • 8.2.3.2 Canada Mass Spectrometry Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.2.3.3 Competitive Scenario
      • 8.2.3.4 Regulatory Framework
  • 8.3 Europe
    • 8.3.1 Europe Mass Spectrometry Market Estimated And Forecasts, 2018 - 2030 (USD Million)
    • 8.3.2 Uk
      • 8.3.2.1 Key Country Dynamics
      • 8.3.2.2 Uk Mass Spectrometry Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.3.2.3 Competitive Scenario
      • 8.3.2.4 Regulatory Framework
    • 8.3.3 Germany
      • 8.3.3.1 Key Country Dynamics
      • 8.3.3.2 Germany Mass Spectrometry Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.3.3.3 Competitive Scenario
      • 8.3.3.4 Regulatory Framework
    • 8.3.4 France
      • 8.3.4.1 Key Country Dynamics
      • 8.3.4.2 France Mass Spectrometry Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.3.4.3 Competitive Scenario
      • 8.3.4.4 Regulatory Framework
    • 8.3.5 Spain
      • 8.3.5.1 Key Country Dynamics
      • 8.3.5.2 Spain Mass Spectrometry Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.3.5.3 Competitive Scenario
      • 8.3.5.4 Regulatory Framework
    • 8.3.6 Italy
      • 8.3.6.1 Key Country Dynamics
      • 8.3.6.2 Italy Mass Spectrometry Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.3.6.3 Competitive Scenario
      • 8.3.6.4 Regulatory Framework
    • 8.3.7 Denmark
      • 8.3.7.1 Key Country Dynamics
      • 8.3.7.2 Denmark Mass Spectrometry Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.3.7.3 Competitive Scenario
      • 8.3.7.4 Regulatory Framework
    • 8.3.8 Sweden
      • 8.3.8.1 Key Country Dynamics
      • 8.3.8.2 Sweden Mass Spectrometry Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.3.8.3 Competitive Scenario
      • 8.3.8.4 Regulatory Framework
    • 8.3.9 Norway
      • 8.3.9.1 Key Country Dynamics
      • 8.3.9.2 Norway Mass Spectrometry Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.3.9.3 Competitive Scenario
      • 8.3.9.4 Regulatory Framework
    • 8.3.10 Rest Of Europe Mass Spectrometry Market Estimates And Forecasts, 2018 - 2030 (USD MilliON)
  • 8.4 Asia Pacific
    • 8.4.1 Asia Pacific Mass Spectrometry Market Estimated And Forecasts, 2018 - 2030 (USD Million)
    • 8.4.2 Japan
      • 8.4.2.1 Key Country Dynamics
      • 8.4.2.2 Japan Mass Spectrometry Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.4.2.3 Competitive Scenario
      • 8.4.2.4 Regulatory Framework
    • 8.4.3 China
      • 8.4.3.1 Key Country Dynamics
      • 8.4.3.2 China Mass Spectrometry Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.4.3.3 Competitive Scenario
      • 8.4.3.4 Regulatory Framework
    • 8.4.4 India
      • 8.4.4.1 Key Country Dynamics
      • 8.4.4.2 India Mass Spectrometry Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.4.4.3 Competitive Scenario
      • 8.4.4.4 Regulatory Framework
    • 8.4.5 Australia
      • 8.4.5.1 Key Country Dynamics
      • 8.4.5.2 Australia Mass Spectrometry Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.4.5.3 Competitive Scenario
      • 8.4.5.4 Regulatory Framework
    • 8.4.6 Thailand
      • 8.4.6.1 Key Country Dynamics
      • 8.4.6.2 Thailand Mass Spectrometry Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.4.6.3 Competitive Scenario
      • 8.4.6.4 Regulatory Framework
    • 8.4.7 South Korea
      • 8.4.7.1 Key Country Dynamics
      • 8.4.7.2 South Korea Mass Spectrometry Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.4.7.3 Competitive Scenario
      • 8.4.7.4 Regulatory Framework
    • 8.4.8 Rest Of Asia Pacific Mass Spectrometry Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.5 Latin America
    • 8.5.1 Latin America Mass Spectrometry Market Estimated And Forecasts, 2018 - 2030 (USD Million)
    • 8.5.2 Brazil
      • 8.5.2.1 Key Country Dynamics
      • 8.5.2.2 Brazil Mass Spectrometry Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.5.2.3 Competitive Scenario
      • 8.5.2.4 Regulatory Framework
    • 8.5.3 Mexico
      • 8.5.3.1 Key Country Dynamics
      • 8.5.3.2 Mexico Mass Spectrometry Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.5.3.3 Competitive Scenario
      • 8.5.3.4 Regulatory Framework
    • 8.5.4 Argentina
      • 8.5.4.1 Key Country Dynamics
      • 8.5.4.2 Argentina Mass Spectrometry Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.5.4.3 Competitive Scenario
      • 8.5.4.4 Regulatory Framework
    • 8.5.5 Rest Of Latin America Mass Spectrometry Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.6 Middle East And Africa
    • 8.6.1 Middle East And Africa Mass Spectrometry Market Estimated And Forecasts, 2018 - 2030 (USD Million)
    • 8.6.2 South Africa
      • 8.6.2.1 Key Country Dynamics
      • 8.6.2.2 South Africa Mass Spectrometry Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.6.2.3 Competitive Scenario
      • 8.6.2.4 Regulatory Framework
    • 8.6.3 Saudi Arabia
      • 8.6.3.1 Key Country Dynamics
      • 8.6.3.2 Saudi Arabia Mass Spectrometry Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.6.3.3 Competitive Scenario
      • 8.6.3.4 Regulatory Framework
    • 8.6.4 UAE
      • 8.6.4.1 Key Country Dynamics
      • 8.6.4.2 UAE Mass Spectrometry Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.6.4.3 Competitive Scenario
      • 8.6.4.4 Regulatory Framework
    • 8.6.5 Kuwait
      • 8.6.5.1 Key Country Dynamics
      • 8.6.5.2 Kuwait Mass Spectrometry Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.6.5.3 Competitive Scenario
      • 8.6.5.4 Regulatory Framework
      • 8.6.5.5 Rest Of MEA Mass Spectrometry Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 9 Competitive Landscape

  • 9.1 Company Categorization
  • 9.2 Recent Developments & Impact Analysis by Key Market Participants
  • 9.3 Company Market Share Analysis, 2024
  • 9.4 Key Company Profiles
    • 9.4.1 THERMO FISHER SCIENTIFIC, INC.
      • 9.4.1.1 Company overview
      • 9.4.1.2 Financial performance
      • 9.4.1.3 Product benchmarking
      • 9.4.1.4 Strategic initiatives
    • 9.4.2 AGILENT TECHNOLOGIES, INC.
      • 9.4.2.1 Company overview
      • 9.4.2.2 Financial performance
      • 9.4.2.3 Product benchmarking
      • 9.4.2.4 Strategic initiatives
    • 9.4.3 DANAHER CORPORATION (SCEIX)
      • 9.4.3.1 Company overview
      • 9.4.3.2 Financial performance
      • 9.4.3.3 Product benchmarking
      • 9.4.3.4 Strategic initiatives
    • 9.4.4 WATERS CORPORATION
      • 9.4.4.1 Company overview
      • 9.4.4.2 Financial performance
      • 9.4.4.3 Product benchmarking
      • 9.4.4.4 Strategic initiatives
    • 9.4.5 BRUKER CORPORATION
      • 9.4.5.1 Company overview
      • 9.4.5.2 Financial performance
      • 9.4.5.3 Product benchmarking
      • 9.4.5.4 Strategic initiatives
    • 9.4.6 SHIMADZU CORPORATION
      • 9.4.6.1 Company overview
      • 9.4.6.2 Financial performance
      • 9.4.6.3 Product benchmarking
      • 9.4.6.4 Strategic initiatives
    • 9.4.7 PERKINELMER, INC.
      • 9.4.7.1 Company overview
      • 9.4.7.2 Financial performance
      • 9.4.7.3 Product benchmarking
      • 9.4.7.4 Strategic initiatives
    • 9.4.8 RIGAKU CORPORATION
      • 9.4.8.1 Company overview
      • 9.4.8.2 Financial performance
      • 9.4.8.3 Product benchmarking
      • 9.4.8.4 Strategic initiatives
    • 9.4.9 LECO CORPORATION
      • 9.4.9.1 Company overview
      • 9.4.9.2 Financial performance
      • 9.4.9.3 Product benchmarking
      • 9.4.9.4 Strategic initiatives
    • 9.4.10 JEOL LTD.
      • 9.4.10.1 Company overview
      • 9.4.10.2 Financial performance
      • 9.4.10.3 Product benchmarking
      • 9.4.10.4 Strategic initiatives

Chapter 10 Conclusion

ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦